Divi’s Laboratories Ltd., incorporated in the year 1990, is a Large Cap company (having a market cap of Rs 90417.27 Crore) operating in Pharmaceuticals sector.
Financials
For the quarter ended 31-12-2020, the company reported a Consolidated Total Income of Rs 1720.76 Crore, down -2.39 % from last quarter Total Income of Rs 1762.94 Crore and up 19.67 % from last year same quarter Total Income of Rs 1437.93 Crore. Company reported net profit after tax of Rs 470.62 Crore in latest quarter.
Investment Rationale
Price rebounding from 50 weeks EMA and the 80% retracement of previous major rally (Rs 2,985-3,915), thus provides favourable risk reward set up
Promoter/FII Holdings
Promoters held 52 per cent stake in the company as of June 30, 2020, while FIIs held 18.2 per cent, DIIs 15.6 per cent and public and others 14.2 per cent.
